Chronic obstructive pulmonary disease and cardiovascular risk: insights from the NAVIGATOR trial.
Resource Type
Report
Authors
de Barros e Silva PG; Brazilian Clinical Research Institute, Sao Paulo, Brazil.; Califf RM; Duke Translational Medicine Institute, Duke University Medical Center, Durham, NC, United States.; Sun JL; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, United States.; McMurray JJ; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.; Holman R; Diabetes Trials Unit, Oxford Center for Diabetes, Endocrinology, and Metabolism, University of Oxford, Oxford, UK.; Haffner S; San Antonio, TX, United States.; Thomas L; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, United States.; Lopes RD; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, United States. Electronic address: renato.lopes@duke.edu.
Source
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8200291 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1874-1754 (Electronic) Linking ISSN: 01675273 NLM ISO Abbreviation: Int J Cardiol Subsets: MEDLINE